(Q33450688)
Statements
Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon (English)
Green MD
Speyer JL
Hochster HS
Liebes LF
Dunleavy S
Widman T
Wernz JC
Blum RH
scientific article
No description defined